Intensive Care Unit Model of Modern Hospital: Genomically Oriented and Biology-Based

  • Kartik PrabhakaranEmail author
  • Rifat Latifi


Despite modern advances in technology and our understanding of biology, current critical care can be characterized as imprecise. Although evidence-based clinical outcome research can serve as a “guide” to best practices in critical care, emerging technology in bioinformatics and the genetic basis of disease must service as a platform upon which critical care treatment plans can be tailored to the individual patient. Enthusiasm and progress in genomically oriented medicine should be modeled after early success observed in other areas of medicine such as oncology, psychiatry, pulmonology, and cardiology where the genetic basis of disease has led to precise algorithms for treatment based upon individualized patient biology as opposed to disease pathophysiology.


Critical care Genomics Biology Clinical trials Precision medicine 


  1. 1.
    Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med. 2012;366(6):489–91.CrossRefGoogle Scholar
  2. 2.
    Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860–921.CrossRefGoogle Scholar
  3. 3.
    Seymour CW, Gomez H, Chang CCH, Clermont G, Kellum JA, Kennedy J, Yende S, Angus DC. Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness. Crit Care. 2017;21:257.CrossRefGoogle Scholar
  4. 4.
    Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353(16):1659–72.CrossRefGoogle Scholar
  5. 5.
    Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362:2380–8.CrossRefGoogle Scholar
  6. 6.
    Nassan M, Nicholson WT, Elliott MA, Rohrer Vitek CR, Black JL, Frye MA. Pharmacokinetic pharmacogenetic prescribing guidelines for antidepressants: a template for psychiatric precision medicine. Mayo Clin Proc. 2016;91:897–907.CrossRefGoogle Scholar
  7. 7.
    Rogers GB, Wesselingh S. Precision respiratory medicine and the microbiome. Lancet Respir Med. 2016;4:73–82.CrossRefGoogle Scholar
  8. 8.
    Ware LB, Koyama T, Zhao Z, Janz DR, Wickersham N, Bernard GR, et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care. 2013;17:R253.CrossRefGoogle Scholar
  9. 9.
    Maslove DM, Tang BM, McLean AS. Identification of sepsis subtypes in critically ill adults using gene expression profiling. Crit Care. 2012;16:R183.CrossRefGoogle Scholar
  10. 10.
    Christaki E, Giamarellos-Bourboulis EJ. The beginning of personalized medicine in sepsis: small steps to a bright future. Clin Genet. 2014;86:56–61.CrossRefGoogle Scholar
  11. 11.
    Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest. 2015;147:1539–10.CrossRefGoogle Scholar
  12. 12.
    Levy MM. Early goal-directed therapy: what do we do now? Crit Care. 2014;18(6):705.CrossRefGoogle Scholar
  13. 13.
    Prasad M, Christie JD, Bellamy SL, Rubenfeld GD, Kahn JM. The availability of clinical protocols in US teaching intensive care units. J Crit Care. 2010;25(4):610–9.CrossRefGoogle Scholar
  14. 14.
    Rivers E, Nguyen B, Havstad S, Ressler J, Mussin A, Knoblich B, Peterson E, Tomlanovich M, for the Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–77.CrossRefGoogle Scholar
  15. 15.
    Needham DM, Colantuoni E, Mendez-Tellez PA, et al. Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study. BMJ. 2012;344:e2124.CrossRefGoogle Scholar
  16. 16.
    Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med. 1996;335(25):1864–9.CrossRefGoogle Scholar
  17. 17.
    Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126–34.CrossRefGoogle Scholar
  18. 18.
    Investigators PCESS, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T, Wang HE, Hou PC, LoVecchio F, Filbin MR, Shapiro NI, Angus DC. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683–93.CrossRefGoogle Scholar
  19. 19.
    ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496–506. Scholar
  20. 20.
    Sevransky JE, Checkley W, Herrera P, et al. Protocols and hospital mortality in critically ill patients: the United States critical illness and injury trials group critical illness outcomes study. Crit Care Med. 2015;43(10):2076–84.CrossRefGoogle Scholar
  21. 21.
    Shi D, Song Z, Yin J, et al. Genetic variation in the tissue factor gene is associated with clinical outcome in severe sepsis patients. Crit Care. 2014;18(6):631.CrossRefGoogle Scholar
  22. 22.
    Scherag A, Schoneweck F, Kesselmeier M, et al. Genetic factors of the disease course after sepsis: a genome-wide study for 28 day mortality. EBioMedicine. 2016;12:239–46.CrossRefGoogle Scholar
  23. 23.
    Garcia-Laorden MI, Lorente JA, Flores C, et al. Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise. Ann Transl Med. 2017;5(14):283.CrossRefGoogle Scholar
  24. 24.
    Meyer NJ, Feng R, Li M, et al. IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist. Am J Respir Crit Care Med. 2013;187(9):950–9.CrossRefGoogle Scholar
  25. 25.
    Marini JJ, De Backer D, Ince C, et al. Seven unconfirmed ideas to improve future ICU practice. Crit Care. 2017;21(Suppl 3):315.CrossRefGoogle Scholar
  26. 26.
    Cuenca AG, Gentile LF, Lopez MC, et al. Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients. Crit Care Med. 2013;41(5):1175–85.CrossRefGoogle Scholar
  27. 27.
    Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA. 2018;319(7):698–710.CrossRefGoogle Scholar
  28. 28.
    David SP, Johnson SG, Berger AC, et al. Making personalized health care even more personalized: insights from activities of the IOM genomics roundtable. Ann Fam Med. 2015;13(4):373–80.CrossRefGoogle Scholar
  29. 29.
    Wiesenack C, Fiegl C, Keyser A, et al. Continuously assessed right ventricular end-diastolic volume as a marker of cardiac preload and fluid responsiveness in mechanically ventilated cardiac surgical patients. Crit Care. 2005;9(3):R226–33.CrossRefGoogle Scholar
  30. 30.
    Allardet-Servent J, Lebsir M, Dubroca C, et al. Point-of-care versus central laboratory measurements of hemoglobin, hematocrit, glucose, bicarbonate and electrolytes: a prospective observational study in critically ill patients. PLoS One. 2017;12(1):e0169593.CrossRefGoogle Scholar
  31. 31.
    Da Luz LT, Nascimento B, Shankarakutty AK, et al. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care. 2014;18(5):518.CrossRefGoogle Scholar
  32. 32.
    Chambers DA, Feero WG, Khoury MJ. Convergence of implementation science, precision medicine, and the learning health care system: a new model for biomedical research. JAMA. 2016;315(18):1941–2.CrossRefGoogle Scholar
  33. 33.
    Bierman AS, Tinetti ME. Precision medicine to precision care: managing multimorbidity. Lancet. 2016;388(10061):2721–3.CrossRefGoogle Scholar
  34. 34.
    Celi LA, Mark RG, Stone DJ, Montgomery RA. “Big data” in the intensive care unit. Closing the data loop. Am J Respir Crit Care Med. 2013;187:1157–60.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of SurgeryWestchester Medical CenterValhallaUSA
  2. 2.New York Medical College, School of Medicine, Department of Surgery and Westchester Medical CenterValhallaUSA

Personalised recommendations